

For Subqutaneous Injection
Composition: Semaglutide
Dosage: 0.25 mg/pen
Form: Pre-filled Pen
Unit: 1 Pen
Manufactured by Novo Nordisk
Name: Wegovy 0.25 mg
Active Life: Approximately 1 week
Drug Class: GLP-1 receptor agonist (Glucagon-like peptide-1 receptor agonist)
Detection Time: Not typically relevant as it is not a controlled substance commonly tested for in standard drug panels
Chemical Structure: C187H291N45O59
Common Doses: Up to 2.4 mg once weekly
Blood pressure: May help reduce blood pressure in patients
Acne: No
Water retention: Minimal to none
Aromatisation: No
Liver toxicity: No direct hepatotoxicity, but should be used with caution in patients with hepatic impairment
Decrease HPTA function: No
Please log in to write Wegovy 0.25 mg review.
For Subqutaneous Injection
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
For Subqutaneous Injection
Composition: Semaglutide
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial
Manufactured by Stealth Labs USA
Laboratory Test: View Lab Report
Shipped Without Label!